Related Experiment Video
Updated: May 5, 2026

Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique
Published on: March 14, 2016
Integration of Multi-Rotor and Multi-Conjugation: Ultrahigh Absorption Coefficient Dye Enables NIR-II Fluorescence
Guining Cao1, Jiacheng Tang1, Meijing Wang1
1School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, Guangdong, 510060, China.
Abstract:
The progressive accumulation of mutated genes in cancer cells facilitates tumor immune escape. Photothermal immunotherapy addresses this problem by triggering immunogenic cell death (ICD) through photothermal treatment, releasing endogenous immunogenic neoantigens. Herein, guided by the "multi-rotor & multi-conjugation" concept, near-infrared region II (NIR-II) cyanine molecules are designed with varying numbers of benzene rotors. TPE-CyA, with more benzene rotors, features an ultra-high molar extinction coefficient (1.786 × 105 m-1 cm-1), a well-balanced fluorescence quantum yield (0.99%), and a 45.72% photothermal conversion efficiency. TPE-CyA nanoparticles (TPE-CyA NPs) are ideal for high-resolution NIR-II fluorescence imaging and angiography. Imaging-guided TPE-CyA NPs show great potential in NIR-II photothermal immunotherapy by effectively suppressing bilateral tumor growth and liver metastasis without additional immunoadjuvants. Moreover, the photothermal immunotherapy guided by TPE-CyA NPs can induce ICD, promote dendritic cell (DCs) maturation, increase T-cell infiltration in tumors, and activate systemic immunity to prevent metastasis and recurrence. This research highlights the potential of NIR-II photothermal therapy in tumor cell ablation, immune activation for cancer and vascular diagnostics, presenting a novel strategy for both primary and metastatic cancers.
Insights
This study introduces TPE-CyA nanoparticles for near-infrared II photothermal immunotherapy. These nanoparticles effectively suppress tumor growth and metastasis by inducing immunogenic cell death and activating systemic immunity.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Research
Background:
- Cancer cells accumulate mutations, leading to immune escape.
- Photothermal immunotherapy triggers immunogenic cell death (ICD) and releases neoantigens.
- Near-infrared II (NIR-II) region offers advantages for deep tissue imaging and therapy.
Purpose of the Study:
- To design novel cyanine molecules for NIR-II photothermal immunotherapy.
- To evaluate the efficacy of TPE-CyA nanoparticles in cancer treatment and imaging.
- To investigate the immunomodulatory effects of NIR-II photothermal immunotherapy.
Main Methods:
- Designed NIR-II cyanine molecules based on the "multi-rotor & multi-conjugation" concept.
- Synthesized and characterized TPE-CyA nanoparticles (TPE-CyA NPs).
- Evaluated TPE-CyA NPs for NIR-II fluorescence imaging, angiography, and photothermal immunotherapy in vivo.
Main Results:
- TPE-CyA exhibited high molar extinction coefficient and photothermal conversion efficiency.
- TPE-CyA NPs enabled high-resolution NIR-II imaging and angiography.
- Imaging-guided TPE-CyA NPs suppressed bilateral tumor growth and liver metastasis, inducing ICD and systemic immunity.
Conclusions:
- TPE-CyA nanoparticles represent a promising strategy for NIR-II photothermal immunotherapy.
- This approach activates anti-tumor immunity, preventing metastasis and recurrence.
- Highlights the potential of NIR-II photothermal therapy for cancer treatment and immune activation.

